Literature DB >> 6883268

Accrual of radiotherapy patients to clinical trials.

J Y Lee, S R Breaux.   

Abstract

Recruitment of patients to clinical trials is a multi-stage process. To participate in a protocol, a patient must meet all the eligibility requirements; the physicians managing the patient must be amenable to enrolling the patient on protocol; and finally, the patient must consent to participate. In 1979, 64 clinical trials were open to patient accrual in the Division of Radiation Oncology, Mallinckrodt Institute of Radiology, St. Louis, Missouri. A total of 1103 cases were reviewed. Two hundred sixty-three patients were eligible for one of the protocols, of whom 124 were successfully recruited. The reasons for ineligibility and nonparticipation are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6883268     DOI: 10.1002/1097-0142(19830915)52:6<1014::aid-cncr2820520614>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

2.  Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.

Authors:  J E Veney; W P Kory; J M Barnsley; A D Kaluzny
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

3.  Attitude of African-Americans regarding prostate cancer clinical trials.

Authors:  S B Robinson; M Ashley; M A Haynes
Journal:  J Community Health       Date:  1996-04

4.  Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?

Authors:  K Al-Baimani; H Jonker; T Zhang; G D Goss; S A Laurie; G Nicholas; P Wheatley-Price
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

5.  Impact of prior cancer on eligibility for lung cancer clinical trials.

Authors:  David E Gerber; Andrew L Laccetti; Lei Xuan; Ethan A Halm; Sandi L Pruitt
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

6.  Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

Authors:  Sandra Garcia; Ajit Bisen; Jingsheng Yan; Xian-Jin Xie; Suresh Ramalingam; Joan H Schiller; David H Johnson; David E Gerber
Journal:  J Thorac Oncol       Date:  2017-08-09       Impact factor: 15.609

7.  Enhancing decision making about participation in cancer clinical trials: development of a question prompt list.

Authors:  Richard F Brown; Elyse Shuk; Natasha Leighl; Phyllis Butow; Jamie Ostroff; Shawna Edgerson; Martin Tattersall
Journal:  Support Care Cancer       Date:  2010-07-01       Impact factor: 3.603

8.  Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations.

Authors:  Richard F Brown; Carma L Bylund; Yuelin Li; Shawna Edgerson; Phyllis Butow
Journal:  Patient Educ Couns       Date:  2012-03-04

9.  Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Authors:  Lynne Penberthy; Richard Brown; Maureen Wilson-Genderson; Bassam Dahman; Gordon Ginder; Laura A Siminoff
Journal:  Clin Trials       Date:  2012-10-02       Impact factor: 2.486

10.  Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).

Authors:  I Juraskova; P Butow; A Lopez; M Seccombe; A Coates; F Boyle; N McCarthy; L Reaby; J F Forbes
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.